Elite Pharmaceuticals Inc. (OTCMKTS:ELTP – Get Free Report) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.57 and traded as low as $0.4615. Elite Pharmaceuticals shares last traded at $0.4695, with a volume of 974,491 shares.
Elite Pharmaceuticals Price Performance
The stock has a 50 day moving average of $0.52 and a two-hundred day moving average of $0.57. The company has a debt-to-equity ratio of 0.06, a quick ratio of 6.34 and a current ratio of 8.04. The firm has a market capitalization of $505.65 million, a P/E ratio of 47.00 and a beta of 0.32.
About Elite Pharmaceuticals
Elite Pharmaceuticals, Inc is a U.S.-based specialty pharmaceutical company that acquires, develops and markets both branded and generic pharmaceutical products. Headquartered in Houston, Texas, the company focuses on complex dosage forms—including injectables, sterile formulations and oncology therapies—and seeks to address unmet medical needs through advanced drug delivery technologies. Its product portfolio spans therapeutic areas such as pain management, oncology and cardiovascular care.
Since its founding in 2007, Elite Pharmaceuticals has pursued strategic partnerships and licensing agreements to expand its pipeline and manufacturing capabilities.
Read More
- Five stocks we like better than Elite Pharmaceuticals
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Wall Street Alert: Buy AES
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Your “birthright claim” just got activated
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
